Long covid

A new study seeks to find if there is improvement in neurologic symptoms of long COVID.

// 4.7.2022

// 18.6.2022

// 14.6.2022

The CDC is beginning to look at death certificates that indicate more than 100 people who died had long Covid. // 3.6.2022

Our findings point towards respiratory muscle dysfunction as a novel aspect of COVID-19 sequelae. Thus, we strongly advocate for systematic respiratory muscle testing during the diagnostic workup of persistently symptomatic, convalescent COVID-19 patients. // 16.5.2022

The UCLA researchers studied 1038 people enrolled in the UCLA COVID Ambulatory Program between April 2020 and February 2021. Researchers found that 309 of them developed long COVID. // 21.4.2022

Background Long Covid is associated with multiple symptoms and impairment in multiple organs. Cardiac impairment has been reported to varying degrees by varying methodologies in cross-sectional studies. Using cardiac magnetic resonance (CMR), we investigated the 12-month trajectory of cardiac impairment in individuals with Long Covid. // 4.4.2022

Professor Jeremy Nicholson is the Director of the Australian National Phenome Centre at Murdoch University and a leading researcher into Long Covid. His team is working with multiple universities around the world - including Harvard and Cambridge - to try and understand the long term cardiometabolic and other systemic effects of the disease, as well as the impact of Covid-19 in kids. // 2.4.2022

Patients with 'brain fog' during acute COVID-19 had the highest levels of inflammatory markers, offering additional evidence of a neurological basis for post-acute sequelae of SARS-CoV-2 infection. // 1.4.2022

New research hints at why COVID brain fog may persist // 1.4.2022

Background The Covid-19 outbreak has presented many challenges to governments and healthcare systems, including observations of symptoms that persist beyond acute infection labelled as post Covid-19 condition. // 25.3.2022

Long COVID patients who were infected with the Alpha variant of SARS-CoV-2 showed more neurological, cognitive, and emotional problems than those who were infected with the original (wild-type/Wuhan) variant. // 25.3.2022

At 6-12 months post-infection, many patients suffer impairment of daily life and activities, as well as cognition and mental health. // 24.3.2022

Objective: To evaluate the frequency, duration and patterns of long-term coronavirus disease 2019 (COVID-19) symptoms and to analyze risk factors for long-lasting COVID-19 sequelae among hospital employees (HEs). // 22.3.2022

Importance: Multi-organ impairment associated with Long COVID is a significant burden to individuals, populations and health systems, presenting challenges for diagnosis and care provision. Standardised assessment across multiple organs over time is lacking, particularly in non-hospitalised individuals. // 21.3.2022

Comparing brain volume before and after individuals were exposed to SARS-CoV-2, this study documents significant cortical gray matter loss, equivalent to nearly 10 years of aging. // 21.3.2022

A new study estimated long-term COVID-19, or, long COVID, and the trajectory of disease symptoms in a representative sample in the US. // 21.3.2022

Researchers investigated whether residual SARS-CoV-2 antigens and RNA are present in tissues samples of long COVID-19 patients beyond the convalescent phase of COVID-19. //24.2.2022

Scientists all around the world are working to investigate new ways to prevent and treat COVID-19, and recent research has been focusing on the effects of a syndrome commonly called “long COVID.” People affected by this syndrome usually suffer from symptoms like the ones observed in several types of fatigue syndrome. As these syndromes are often linked to mitochondrial dysfunction, researchers hypothesized that a dysfunction in the mitochondrial metabolism might be part of the causes of long COVID. // 4.2.2022

Researchers assessed the effectiveness of COVID-19 vaccines in patients experiencing long COVID. // 21.2.2022

Abstract. Emerging as a new epidemic, long COVID or post-acute sequelae of coronavirus disease 2019 (COVID-19), a condition characterized by the persistence of… // 18.2.2022

We explore what we know so far about risk factors for long COVID, a syndrome characterized by COVID-19 symptoms lasting weeks or months after the initial illness. // 17.2.2022

A new study determined which symptoms are linked with confirmed SARS-CoV-2 infection beyond 12 weeks post-infection in non-hospitalized individuals, and investigated the associated risk-factors of such symptoms. // 17.2.2022

Even getting vaccinated after infection appears to help, review concludes // 16.2.2022

Many women with long COVID who experience COVID-19 symptoms for months have reported changes in their menstrual cycles. What does this mean for them? // 16.2.2022

As of January 2022, at least 60 million individuals are estimated to develop post-acute sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While elevated levels of SARS-CoV-2-specific T cells have been observed in non-specific PASC, little is known about their impact on pulmonary function which is compromised in the majority of these individuals. // 15.2.2022

A new study may provide a partial explanation for the long-term immunologic phenomena associated with COVID-19.

A new study analyzed the impact of long-COVID on women long haulers with respect to various aspects of their social life. // 14.2.2022

Neurological issues, ranging from memory lapses to trouble with attention, have been widely reported after recovery from severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection. Unfortunately, there is limited information about pathways to recovery after severe COVID hospitalization. Now, a prospective study of 4,491 patients hospitalized with COVID suggests neurological recovery can take at least a year. // 13.2.2022